Doravirine, Rifapentine and Isoniazid Interaction

Clinical trial NCT03886701 · COMPLETED

Trial details

NCT number: NCT03886701
Sponsor: Walter K. Kraft
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Latent Tuberculosis Human Immunodeficiency Virus Rifamycins Causing Adverse Effects in Therapeutic Use Drug Interaction Potentiation

Start date: 2019-04-22
Primary completion: 2019-05-20
Enrollment: 11

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.